# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4015418 | U | Cysteamine reactivity of the compound in PBS assessed as second order rate constant for free cysteamine release at 250 uM and pH 7.4 after 90 mins by DTNB reagent based RP-UHPLC analysis | 15 | ALA4014309 | assay format | Scientific Literature | ||
2. | ALA4015424 | A | Cytotoxicity against human THP1 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 16 | ALA4014309 | cell-based format | Scientific Literature | |
3. | ALA4015425 | A | Cytotoxicity against human THP1 cells assessed as cell viability at 100 uM after 72 hrs by MTT assay | Homo sapiens | 9 | ALA4014309 | cell-based format | Scientific Literature | |
4. | ALA4015426 | B | Inhibition of recombinant human NLRP3 ATPase assessed as hydrolysis of ATP at 100 uM preincubated for 15 mins followed by addition of ATP measured after 40 mins by ADP-Glo assay | Homo sapiens | 16 | ALA4014309 | single protein format | Scientific Literature | |
5. | ALA4015427 | B | Inhibition of recombinant human NLRP3 ATPase assessed as hydrolysis of ATP at 50 uM preincubated for 15 mins followed by addition of ATP measured after 40 mins by ADP-Glo assay | Homo sapiens | 16 | ALA4014309 | single protein format | Scientific Literature | |
6. | ALA4015428 | B | Inhibition of NLRP3 in PMA-differentiated and LPS-primed human THP1 cells assessed as decrease in ATP-induced pyroptosis measured as LDH activity at 10 uM preincubated for 1 hr followed by ATP addition measured after 1 hr by colorimetric assay relative to control | Homo sapiens | 13 | ALA4014309 | assay format | Scientific Literature | |
7. | ALA4015457 | A | Metabolic stability in Sprague-Dawley rat liver microsomes at 100 uM after 2 hrs in presence of NADPH-generating system by UHPLC-MS analysis | Rattus norvegicus | 1 | ALA4014309 | assay format | Scientific Literature | |
8. | ALA4015485 | A | Drug level in Sprague-Dawley rat liver microsomes treated with INF39 at 100 uM up to 2 hrs by UHPLC-MS analysis | Rattus norvegicus | 1 | ALA4014309 | assay format | Scientific Literature | |
9. | ALA4015486 | B | Inhibition of recombinant human NLRP3 ATPase assessed as hydrolysis of ATP preincubated for 15 mins followed by addition of ATP measured after 40 mins by ADP-Glo assay | Homo sapiens | 10 | ALA4014309 | single protein format | Scientific Literature | |
10. | ALA4015491 | A | Drug level in Sprague-Dawley rat ileum tract treated with INF39 at 12.5 mg as suspension in olive oil measured after 2 hrs by UHPLC-M | Rattus norvegicus | 1 | ALA4014309 | assay format | Scientific Literature | |
11. | ALA4015492 | A | Drug level in Sprague-Dawley rat duodenum treated with INF39 at 12.5 mg as suspension in olive oil measured after 2 hrs by UHPLC-M | Rattus norvegicus | 1 | ALA4014309 | tissue-based format | Scientific Literature | |
12. | ALA4015493 | A | Drug level in Sprague-Dawley rat jejunum treated with INF39 at 12.5 mg as suspension in olive oil measured after 2 hrs by UHPLC-M | Rattus norvegicus | 1 | ALA4014309 | tissue-based format | Scientific Literature |